Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

Tagged vidal · clear

USPTO Rescinds 2022 Guidance on PTAB Discretionary Denials, Reverting to Original Fintiv Framework

On February 28, 2025, the United States Patent and Trademark Office (USPTO) rescinded the June 21, 2022, memorandum titled “Interim Procedure for Discretionary Denials in AIA Post-Grant Proceedings with Parallel District Court Litigation.”…

March 4, 2025ITC / Section 3372 min read

USPTO Policy

USPTO Issues Comprehensive Guidance on Inventorship of AI-assisted Inventions

In a landmark move aimed at addressing the complexities arising from the intersection of artificial intelligence (AI) and patent law, the U.S. Patent and Trademark Office (USPTO) has issued detailed guidance regarding the determination of inventorship for…

February 13, 2024USPTO Policy2 min read